- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Nausea and vomiting
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 611KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 114KB)
Netupitant with palonosetron – March 2023
Netupitant with palonosetron: Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride); Akynzeo®
Last updated
30 June 2023